Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Cost of RevenueLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsReceivables - Net
Ratios

Guided Therapeutics (GTHP) Revenue (Gross) (2023 - 2024)

Guided Therapeutics' Revenue (Gross) history spans 2 years, with the latest figure at $3000.0 for Q1 2024.

  • For Q1 2024, Revenue (Gross) changed N/A year-over-year to $3000.0; the TTM value through Dec 2024 reached $3000.0, down 50.0%, while the annual FY2024 figure was $3000.0, 50.0% down from the prior year.
  • Revenue (Gross) for Q1 2024 was $3000.0 at Guided Therapeutics, down from $6000.0 in the prior quarter.
  • Across five years, Revenue (Gross) topped out at $6000.0 in Q4 2023 and bottomed at $3000.0 in Q1 2024.